Works matching IS 0344-5704 AND VI 69 AND IP 6 AND DT 2012
Results: 34
RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1[alpha] and inhibition phosphorylation of AKT and mTOR.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
- Published in:
- 2012
- By:
- Publication type:
- journal article
An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1477, doi. 10.1007/s00280-012-1846-6
- By:
- Publication type:
- Article
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1557, doi. 10.1007/s00280-012-1864-4
- By:
- Publication type:
- Article
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1669, doi. 10.1007/s00280-012-1840-z
- By:
- Publication type:
- Article
Ascorbic acid and healthy lymphocytes: a way to explain anticancer activity?
- Published in:
- 2012
- By:
- Publication type:
- Letter
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl hematological malignancies.
- Published in:
- 2012
- By:
- Publication type:
- Report
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1407, doi. 10.1007/s00280-012-1848-4
- By:
- Publication type:
- Article
Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1413, doi. 10.1007/s00280-012-1847-5
- By:
- Publication type:
- Article
Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1423, doi. 10.1007/s00280-012-1851-9
- By:
- Publication type:
- Article
A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1433, doi. 10.1007/s00280-012-1845-7
- By:
- Publication type:
- Article
The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1443, doi. 10.1007/s00280-012-1849-3
- By:
- Publication type:
- Article
Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1449, doi. 10.1007/s00280-012-1842-x
- By:
- Publication type:
- Article
Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1467, doi. 10.1007/s00280-012-1856-4
- By:
- Publication type:
- Article
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1457, doi. 10.1007/s00280-012-1850-x
- By:
- Publication type:
- Article
Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1499, doi. 10.1007/s00280-012-1853-7
- By:
- Publication type:
- Article
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1487, doi. 10.1007/s00280-012-1852-8
- By:
- Publication type:
- Article
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1507, doi. 10.1007/s00280-012-1854-6
- By:
- Publication type:
- Article
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1519, doi. 10.1007/s00280-012-1855-5
- By:
- Publication type:
- Article
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1529, doi. 10.1007/s00280-012-1858-2
- By:
- Publication type:
- Article
Transient elevation of serum cystatin C concentrations during perioperative cisplatin-based chemotherapy in esophageal cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1537, doi. 10.1007/s00280-012-1860-8
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1545, doi. 10.1007/s00280-012-1862-6
- By:
- Publication type:
- Article
Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1567, doi. 10.1007/s00280-012-1863-5
- By:
- Publication type:
- Article
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1583, doi. 10.1007/s00280-012-1865-3
- By:
- Publication type:
- Article
The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1591, doi. 10.1007/s00280-012-1866-2
- By:
- Publication type:
- Article
Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1601, doi. 10.1007/s00280-012-1869-z
- By:
- Publication type:
- Article
An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1617, doi. 10.1007/s00280-012-1872-4
- By:
- Publication type:
- Article
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1625, doi. 10.1007/s00280-012-1871-5
- By:
- Publication type:
- Article
RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1α and inhibition phosphorylation of AKT and mTOR.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1633, doi. 10.1007/s00280-012-1873-3
- By:
- Publication type:
- Article
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1641, doi. 10.1007/s00280-012-1875-1
- By:
- Publication type:
- Article
Lenalidomide in solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1393, doi. 10.1007/s00280-012-1874-2
- By:
- Publication type:
- Article
Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1647, doi. 10.1007/s00280-012-1886-y
- By:
- Publication type:
- Article